Commentary

Let's End the Small Renal Mass Dilemma

Let's End the Small Renal Mass Dilemma By

The vow never to treat SRMs may seem hard to believe and self-defeating.

Hemoglobin Levels Fall, Transfusions On the Rise

Hemoglobin Levels Fall, Transfusions On the Rise By

Two studies presented at the recent NKF Spring Clinical Meetings provide more evidence of a trend toward decreasing use of ESAs and decreasing hemoglobin levels.

Reflections on the EAU Annual Congress

Reflections on the EAU Annual Congress By

Having just returned from the always-stimulating European Association of Urology annual congress, I'd like to share a few impressions.

Why Not 24/7 Dialysis Urgent Care?

Why Not 24/7 Dialysis Urgent Care? By

Almost half a million Americans depend on chronic dialysis therapy to survive.

Physicians: Managers of Risk

Physicians: Managers of Risk By

Physicians are more often defined by their ability to diagnose, treat, and research a disease than their willingness to manage its spectrum of risk.

The Rise of the Coffee Shop Doctor

The Rise of the Coffee Shop Doctor By

How often have you met for business in a Starbucks, Coffee Bean, or any other coffee shop?

Highlights of Kidney Week 2012

Highlights of Kidney Week 2012 By

Kidney Week 2012, held in San Diego, is now history and as usual I like to reflect on the world's biggest and most prestigious meeting for kidney specialists.

Obesity and Prostate Cancer Risk

Obesity and Prostate Cancer Risk By

Although data suggest that cancer rates are also higher in obese patients, the associations are largely based on observational/population studies.

A Rising Epidemic of Foamy Urine

A Rising Epidemic of Foamy Urine By

Historically, foamy urine is considered a warning sign for probable kidney disease.

CT and Stones: Can We Do Better with Less?

CT and Stones: Can We Do Better with Less? By

Cross-sectional imaging now substitutes for physical diagnosis in most emergency rooms.

How About Twice-Weekly Hemodialysis?

How About Twice-Weekly Hemodialysis? By

In recent trips to India, China, Brazil, and other countries, I was intrigued by large numbers of patients with end-stage renal disease who underwent hemodialysis (HD) less frequently than three times a week.

Outlook Brightens for CRPC Patients

Outlook Brightens for CRPC Patients By

In the past few years, urologists have seen some significant developments related to the treatment of metastatic castration-resistant prostate cancer (CRPC).

Put Women Back on the Research Agenda

Put Women Back on the Research Agenda By

Unfortunately, in the past few years, very few studies have looked at issues regarding gender and CKD, and of most concern, looking at response to therapy.

Prostate Cancer Screening: Moving Beyond PSA

Prostate Cancer Screening: Moving Beyond PSA By

More than 1 million prostate biopsies are performed annually in the United States, predominantly driven by elevations in PSA.

Is U.S. Nephrology Lagging Behind?

Is U.S. Nephrology Lagging Behind? By

As practicing clinicians in the United States, we generally feel privileged, with access to a highly developed and pioneering medical care system along with an advanced and cutting-edge technology in the world's largest economy.

Highlights of the GU Cancers Symposium

Highlights of the GU Cancers Symposium By

The March issue features coverage of the 2012 Genitourinary (GU) Cancers Symposium, which was held in San Francisco.

Let Patients Sleep During Rounds

Let Patients Sleep During Rounds By

How often do you face with the unpleasant task of waking a sleeping patient during your busy rounds? It happens frequently to many clinicians during their inpatient rounds in the hospital.

Highlights of 2011, The Promise of 2012

Highlights of 2011, The Promise of 2012 By

The start of 2012 is a good time to look back on the previous year to see the current state of nephrology. What have been the important findings that occurred in the past year, and what do we have to look forward to in the year ahead?

Kidney Stone Prevention: 'Fact versus Fiction'

Kidney Stone Prevention: 'Fact versus Fiction' By

According to current estimates, kidney stones will develop in one in 10 people during their lifetime. This translates into nearly 30 million people in the United States. Clearly, prevention is paramount when dealing with kidney stones.

ACOs and Productivity Metrics in Medicine

ACOs and Productivity Metrics in Medicine By

Individuals, businesses and nations grapple with how to measure success. Are similar productivity measures warranted in medicine?

The Institute Model: Integrating to Improve Care

The Institute Model: Integrating to Improve Care By

Renal & Urology News was established in 2002 based on recognition of natural synergies of nephrology and urology. The insight was not immediately intuitive, as care delivery remained largely specialty-based.

Should We Start Dialysis As Late As Possible?

Should We Start Dialysis As Late As Possible? By

Traditional nephrology training makes us believe that it is good practice to start maintenance dialysis therapy sooner rather than later. Nevertheless, recent data indicate that we may encounter yet another "old-practice-was-wrong" paradigm shift.

Kidney Cancer vs. ESRD

By By

Incidentally detected renal tumors are increasingly diagnosed in patients with chronic kidney disease.

CKD Stage 3 Needs To Be Redefined

CKD Stage 3 Needs To Be Redefined By

Nephrologists should rethink the screening level and offer a more conservative and meaningful cutoff level, such as an eGFR of 45.

Are All Acute Kidney Injuries "Acute on Chronic"?

Are All Acute Kidney Injuries "Acute on Chronic"? By

Practicing nephrologists are frequently consulted to evaluate acute kidney injury (AKI) as inpatient cases.

The Negative Prostate Biopsy Dilemma

The Negative Prostate Biopsy Dilemma By

The role of PSA as a cancer screening tool has recently been evaluated by several large high profile studies with varying interpretations of the data. Regardless of where one stands on the debate, among the clinical dilemmas of PSA-based screening is the negative biopsy conundrum where the reality remains that the best one can offer is, "Good news Mr. Smith, I don't think you have prostate cancer."

The Pros and Cons of Interventional Nephrology

The Pros and Cons of Interventional Nephrology By

The advantages of this emerging specialty are clear to those involved in vascular access care, but some potential downsides must be considered.

HGPIN: Precursor, Marker, or Meaningless?

HGPIN: Precursor, Marker, or Meaningless? By

The ongoing controversy as to whether premalignant, prostatic lesions are associated with increase risk of developing cancer.

Nephrology In Canada Is Well Supported

By

Many Americans harbor fears about the Canadian health care system, and I would like to clear up some misconceptions.

A Call to Service For Nephrologists

A Call to Service For Nephrologists By

The pending legislation on health care reform can be polarizing, but the motivation supporting it is not.

Renin Mutations As a Cause of Inherited Interstitial Kidney Disease

By

An international research team have identified a number of families suffering from a mutation in the signal peptide of the renin gene that lead to the development of autosomal dominant CKD.

Paid for Good Outcomes Measures

Paid for Good Outcomes Measures By

Who could have guessed that one day physicians would be paid based on the outcomes of patients under their care? This is the imminent reality in nephrology.

If Fat is Good, Is Muscle Better?

If Fat is Good, Is Muscle Better? By

One of recent challenges in nephrology and other internal medicine subspecialties is providing care to an increasing number of patients with chronic disease states and wasting syndrome.

The '30-20-10' Rule for Renal Care

By By By

Nephrologists propose critical action eGFR thresholds to guide management of kidney disease patients.

A More Rational Approach To Renal Mass Surgery

A More Rational Approach To Renal Mass Surgery By

In the absence of level I evidence, physician treatment recommendations are subject not only to the objective (interpretations of the cohort literature and practice guidelines) but also the subjective (training patterns, comfort levels, biases and individual experiences).

Why Not Meals During Dialysis?

Why Not Meals During Dialysis? By

Overnutrition is a major problem in the general population and a serious risk for metabolic syndrome, cardiovascular disease, and death.

Bundling: A Venture into the Unknown

Bundling: A Venture into the Unknown By

Many nephrologists feel increasingly bewildered by heightened discussion about the upcoming bundling system for dialysis patients. The dialysis industry is a unique and giant enterprise serving nearly a half million Americans with end-stage renal disease (ESRD).

Who 'Owns' Health-Care Cost Decisions?

Who 'Owns' Health-Care Cost Decisions? By

The imperfections of our nation's delivery of health care have long been recognized. From poor access for the underinsured and uninsured to potential overutilization by the worried well-insured, the issue has risen to political prominence, with its costs front and center.

Are You Ready to Lead?

Are You Ready to Lead? By

In light of changes in Medicare policies related to ESRD, nephrologists will be called on to play an expanded leadership role in dialysis centers.

Bring Kidney Care into the 21st Century

Bring Kidney Care into the 21st Century By

The growth in the number of patients with end-stage renal disease (ESRD) has tapered and is being offset by continuous improvements in survival. The result is a continued steady increase in the number of patients requiring renal replacement therapy.

The Need for Medical Liability Reform

The Need for Medical Liability Reform By

Two articles in the December 2008 issue of Renal & Urology News add to mounting evidence of the need for medical liability reform, specifically no-fault compensation for medical injuries.

Now Is The Time For Universal Health Care

Now Is The Time For Universal Health Care By

The Medicare End-Stage Renal Disease (ESRD) Program is one of the most significant developments in the history of U.S. health care and an unqualified success.

Funding Prostate Cancer Prevention Efforts

Funding Prostate Cancer Prevention Efforts By

The risk of a man's developing prostate cancer is approximately 18%. Whereas it has been estimated that as much as 60% of this risk is due to environmental exposure (J Urol. 2007;178:S9-S13), developing strategies to mitigate this risk is an important public heath concern.

Important Lessons from ONTARGET

Important Lessons from ONTARGET By

In the past year, an important landmark study demonstrated therapeutic equivalence of the ACE inhibitor ramipril and the angiotensin receptor blocker (ARB) telmisartan in reducing the risk of all forms of atherosclerotic events.

The Need for Renal & Urology News

The Need for Renal & Urology News By

A highly respected senior nephrologist and renowned opinion leader, who also happened to be my good old friend and colleague, asked me why I and some other academicians are involved in supporting such non-peer-reviewed journals as Renal & Urology News (RUN).

Marketing Donor Kidneys: A Personal Viewpoint

Marketing Donor Kidneys: A Personal Viewpoint By

In mid-July 2008, 90,000 Americans were listed by the Organ Procurement and Transplant Network (OPTN) as waiting for a deceased donor kidney.

The Challenges of Nephrology Research

The Challenges of Nephrology Research By

Nephrologists want to improve outcomes and quality of life for renal disease patients through research, but we are faced with major hurdles.

Urine Test Detects Upper Tract TCC

By

With upper tract transitional cell carcinoma (UTTCC), vigilance is the watchword. Detecting this cancer earlier may directly impact patient survival. According to the American Cancer Society, 54,390 new cases and 14,100 deaths in the United States will occur during 2008.

CKD: Speaking the Same Language

CKD: Speaking the Same Language By

Decreases in glomerular filtration rate (GFR) are associated with higher risks of cardiovascular events, hospitalizations, and premature death (N Engl J Med. 2004;351:1296-1305).

In Clinical Trials, Does One Size Fit All?

By

Practicing evidence-based medicine can be difficult in nephrology, where randomized controlled trials are few and far between. In general, the more that trials use hard outcomes such as morbidity and mortality, the greater our confidence that the therapies will have an impact on patients' lives. Using end points such as these, however, often require large sample sizes.